Among REST, CTCF, and CEBPB, CEBPB is the only member that was significantly enriched in C19MChigh group (Fig 5B; REST and CTCF data were not shown) and hence we investigated whether CEBPB is functional in triple negative breast cancers. This evidence concerns the gene CEBPB and triple-negative breast carcinoma.